Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Peterson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Experimental and Molecular Pathology|April 21, 2016
Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancersKristen E Muller, Jonathan D Marotti, Francine B de Abreu, et al.
Methods of Information in Medicine|April 6, 2018
Identifying Associations between Somatic Mutations and Clinicopathologic Findings in Lung Cancer Pathology ReportsNishant Kumar, Laura J Tafe, John H Higgins, et al.
Plos One|March 12, 2014
Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensalAmanda K Dupuy, Marika S David, Lu Li, et al.
Cancer Genetics|April 13, 2016
The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinomaAnna Biernacka, Peter D Tsongalis, Jason D Peterson, et al.
American Journal of Clinical Pathology|October 1, 2016
Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation SequencingJuli-Anne Gardner, Jason D Peterson, Scott A Turner, et al.
Practical Laboratory Medicine|July 3, 2020
Molecular matching and treatment strategies for advanced stage lung cancer at Dartmouth-Hitchcock Medical Center: A three-year review of a Molecular Tumor BoardErica B Bernhardt, Mary D Chamberlin, Ivan P Gorlov, et al.
Neoplasia (New York, N.Y.)|September 24, 2016
Clinical Genotyping of Non-Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver GenesLaura J Tafe, Kirsten J Pierce, Jason D Peterson, et al.
The Journal of Applied Laboratory Medicine|July 8, 2020
Use of Biosynthetic Controls as Performance Standards for Next-Generation Sequencing Assays of Somatic Tumors: A Multilaboratory StudyFrancine B De Abreu, Jason D Peterson, Sophie J Deharvengt, et al.
The Oncologist|July 25, 2015
Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical CenterLaura J Tafe, Ivan P Gorlov, Francine B de Abreu, et al.
Clinical Chemistry|May 14, 2014
Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutationsXiaoying Liu, Kabir Mody, Francine B de Abreu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Experimental and Molecular Pathology|April 21, 2016
Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancersKristen E Muller, Jonathan D Marotti, Francine B de Abreu, et al.
Methods of Information in Medicine|April 6, 2018
Identifying Associations between Somatic Mutations and Clinicopathologic Findings in Lung Cancer Pathology ReportsNishant Kumar, Laura J Tafe, John H Higgins, et al.
Plos One|March 12, 2014
Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensalAmanda K Dupuy, Marika S David, Lu Li, et al.
Cancer Genetics|April 13, 2016
The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinomaAnna Biernacka, Peter D Tsongalis, Jason D Peterson, et al.
American Journal of Clinical Pathology|October 1, 2016
Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation SequencingJuli-Anne Gardner, Jason D Peterson, Scott A Turner, et al.
Practical Laboratory Medicine|July 3, 2020
Molecular matching and treatment strategies for advanced stage lung cancer at Dartmouth-Hitchcock Medical Center: A three-year review of a Molecular Tumor BoardErica B Bernhardt, Mary D Chamberlin, Ivan P Gorlov, et al.
Neoplasia (New York, N.Y.)|September 24, 2016
Clinical Genotyping of Non-Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver GenesLaura J Tafe, Kirsten J Pierce, Jason D Peterson, et al.
The Journal of Applied Laboratory Medicine|July 8, 2020
Use of Biosynthetic Controls as Performance Standards for Next-Generation Sequencing Assays of Somatic Tumors: A Multilaboratory StudyFrancine B De Abreu, Jason D Peterson, Sophie J Deharvengt, et al.
The Oncologist|July 25, 2015
Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical CenterLaura J Tafe, Ivan P Gorlov, Francine B de Abreu, et al.
Clinical Chemistry|May 14, 2014
Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutationsXiaoying Liu, Kabir Mody, Francine B de Abreu, et al.
Pageof 3